New York, USA – November 15, 2023 – In the past few years, complement test technologies have significantly improved the development of novel targeted therapeutics, gene therapy, and personalized medicine. As a leading provider in complement therapeutics, Creative Biolabs offers a comprehensive portfolio of complement testing services to support the development of complement therapeutics.
“Functional or activity tests are pivotal to screening complement defects and complement-targeted drug development,” according to a scientist at Creative Biolabs. “We have been dedicated to this field for years and are committed to using high-quality standards in all operations, including the testing procedures and delivery reports based on the robust and standardized complement assay platform.”
The complement testing services provided at Creative Biolabs include hemolytic inhibition assay, total complement activity test, complement receptor binding assay, and c1q binding assay.
At Creative Biolabs, three distinct tests are used to assess the total complement activity test. CH50 is applied for the classical complement pathway, AH50 for the alternative complement pathway, and LP50 for the lectin complement pathway. The assays for CH50 and AH50 derive from the detection of complement hemolytic activity, whereas LP50 relies on the enzyme immunoassay of the terminal complement complex detection.
In addition, Creative Biolabs provides rapid hemolytic assay and hemolytic inhibition assays for complement function or activity assessment to support the complement system pre-clinical research. The company also offers ready-to-use hemolytic assay products and guidance for those samples deemed unsuitable for postal delivery.
“The complement receptor binding assay focuses on the receptors that interact with the complement system,” stated a scientist at Creative Biolabs. “As their critical role in immune response, these receptors warrant further investigation to enhance understanding. We offer a variety of assays and technologies for receptor-ligand binding screening and quantitation that can be used in complement-based drug discovery.”
Creative Biolabs provides fast and custom complement receptor binding assay services to expedite global research programs, adopting varying methods, such as surface plasmon resonance (SPR), fluorescence polarization (FP), and other common methods.
Learn more information about complement testing services at Creative Biolabs, please visit https://www.creative-biolabs.com/complement-therapeutics.
About Creative Biolabs
Creative Biolabs is dedicated to providing advanced tools and methodologies for immunological research. Built on the heritage of superior quality, result-oriented strategies, and customer-oriented service, Creative Biolabs is committed to fueling scientific discovery in complement therapeutics.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-830-6441Country: United StatesWebsite: https://www.creative-biolabs.com/complement-therapeutics
